These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 23520281)

  • 1. DPP-4 inhibition and neuroprotection: do mechanisms matter?
    Shannon RP
    Diabetes; 2013 Apr; 62(4):1029-31. PubMed ID: 23520281
    [No Abstract]   [Full Text] [Related]  

  • 2. The DPP-4 inhibitor linagliptin counteracts stroke in the normal and diabetic mouse brain: a comparison with glimepiride.
    Darsalia V; Ortsäter H; Olverling A; Darlöf E; Wolbert P; Nyström T; Klein T; Sjöholm Å; Patrone C
    Diabetes; 2013 Apr; 62(4):1289-96. PubMed ID: 23209191
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diabetes: Add-on to metformin in T2DM--linagliptin or glimepiride?
    Christensen M; Knop FK
    Nat Rev Endocrinol; 2012 Oct; 8(10):576-8. PubMed ID: 22926098
    [No Abstract]   [Full Text] [Related]  

  • 4. Frailty and diabetes.
    Sinclair A; Morley J
    Lancet; 2013 Oct; 382(9902):1386-7. PubMed ID: 23948126
    [No Abstract]   [Full Text] [Related]  

  • 5. Linagliptin and newer DPP-4 inhibitors: newer uses and newer indications.
    Kalra S; Unnikrishnan AG; Agrawal N; Singh AK
    Recent Pat Endocr Metab Immune Drug Discov; 2011 Sep; 5(3):197-202. PubMed ID: 21913883
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Linagliptin monotherapy in type 2 diabetes patients for whom metformin is inappropriate: an 18-week randomized, double-blind, placebo-controlled phase III trial with a 34-week active-controlled extension.
    Barnett AH; Patel S; Harper R; Toorawa R; Thiemann S; von Eynatten M; Woerle HJ
    Diabetes Obes Metab; 2012 Dec; 14(12):1145-54. PubMed ID: 22974280
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Linagliptin for elderly patients with type 2 diabetes.
    Salvo F; Moore N; Pariente A
    Lancet; 2014 Jan; 383(9914):307. PubMed ID: 24461122
    [No Abstract]   [Full Text] [Related]  

  • 8. Linagliptin for elderly patients with type 2 diabetes.
    Shah R
    Lancet; 2014 Jan; 383(9914):306-7. PubMed ID: 24461121
    [No Abstract]   [Full Text] [Related]  

  • 9. Linagliptin for elderly patients with type 2 diabetes.
    Yamada T
    Lancet; 2014 Jan; 383(9914):306. PubMed ID: 24461120
    [No Abstract]   [Full Text] [Related]  

  • 10. [Pharmacological and clinical profiles of the DPP-4 inhibitor linagliptin (Trazenta)].
    Ohmura T; Hayashi N; Encinas J
    Nihon Yakurigaku Zasshi; 2012 Apr; 139(4):174-83. PubMed ID: 22498683
    [No Abstract]   [Full Text] [Related]  

  • 11. Linagliptin: a new DPP-4 inhibitor for the treatment of type 2 diabetes mellitus.
    Toth PP
    Postgrad Med; 2011 Jul; 123(4):46-53. PubMed ID: 21680988
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Linagliptin for elderly patients with type 2 diabetes - Authors' reply.
    Barnett AH; von Eynatten M; Patel S; Woerle HJ
    Lancet; 2014 Jan; 383(9914):307-8. PubMed ID: 24461123
    [No Abstract]   [Full Text] [Related]  

  • 13. [Oral Linagliptin (Trajenta)].
    Duh D; Tanret I
    J Pharm Belg; 2013 Mar; (1):41-3. PubMed ID: 23638612
    [No Abstract]   [Full Text] [Related]  

  • 14. Safety and tolerability of linagliptin: a pooled analysis of data from randomized controlled trials in 3572 patients with type 2 diabetes mellitus.
    Schernthaner G; Barnett AH; Emser A; Patel S; Troost J; Woerle HJ; von Eynatten M
    Diabetes Obes Metab; 2012 May; 14(5):470-8. PubMed ID: 22268497
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical utility of the dipeptidyl peptidase-4 inhibitor linagliptin.
    Grunberger G
    Postgrad Med; 2013 May; 125(3):79-90. PubMed ID: 23748509
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Linagliptin, a dipeptidyl peptidase-4 inhibitor with a unique pharmacological profile, and efficacy in a broad range of patients with type 2 diabetes.
    Forst T; Pfützner A
    Expert Opin Pharmacother; 2012 Jan; 13(1):101-10. PubMed ID: 22149370
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Linagliptin: in type 2 diabetes mellitus.
    Scott LJ
    Drugs; 2011 Mar; 71(5):611-24. PubMed ID: 21443284
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Linagliptin: a novel xanthine-based dipeptidyl peptidase-4 inhibitor for treatment of type II diabetes mellitus.
    Ghatak SB; Patel DS; Shanker N; Srivastava A; Deshpande SS; Panchal SJ
    Curr Diabetes Rev; 2011 Sep; 7(5):325-35. PubMed ID: 21916836
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Linagliptin, a dipeptidyl peptidase-4 inhibitor for the treatment of type 2 diabetes.
    Tiwari A
    Curr Opin Investig Drugs; 2009 Oct; 10(10):1091-104. PubMed ID: 19777398
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gliptin versus a sulphonylurea as add-on to metformin.
    Scheen AJ; Paquot N
    Lancet; 2012 Aug; 380(9840):450-2. PubMed ID: 22748818
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.